Why Hims & Hers Health Stock Crushed Novo Nordisk and Viking Therapeutics Today
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and Viking Therapeutics (NASDAQ: VKTX), which is far along in its development of an advanced GLP-1-based obesity treatment. The gainer was Hims & Hers Healthcare (NYSE: HIMS).On the day, the latter company's share price rose by over 5%, while Novo Nordisk's slid by almost 3%, and Viking took a more than 7% tumble.The largest TV advertising platform in the world is American football's Super Bowl, and Hims & Hers was one of the adventurous companies parting with millions of dollars to place an ad during the event. Cleverly targeting the high-demand, weight-loss drug segment, the company dramatically pushed its obesity offerings in a cutting-edge, one-minute spot. Continue reading
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The decliners were Novo Nordisk (NYSE: NVO), famously the company behind Wegovy, and Viking Therapeutics (NASDAQ: VKTX), which is far along in its development of an advanced GLP-1-based obesity treatment. The gainer was Hims & Hers Healthcare (NYSE: HIMS).
On the day, the latter company's share price rose by over 5%, while Novo Nordisk's slid by almost 3%, and Viking took a more than 7% tumble.
The largest TV advertising platform in the world is American football's Super Bowl, and Hims & Hers was one of the adventurous companies parting with millions of dollars to place an ad during the event. Cleverly targeting the high-demand, weight-loss drug segment, the company dramatically pushed its obesity offerings in a cutting-edge, one-minute spot.
